STAT3 activation was found to predict a worse clinical outcome in many other types of cancer, such as cervical cancer [31], esophageal squamous cell carcinoma [32,33], head and neck squamous cell carcinoma [34,35] and thymic epithelial cancer [36]. Here, STAT3 is linked to head and neck squamous cell carcinoma.